• No results found

BIOCHEMISTRY DEPARTMENT

N/A
N/A
Protected

Academic year: 2021

Share "BIOCHEMISTRY DEPARTMENT"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

(1)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

ALBUMIN 33 – 46 g/L

ALK–PHOSPHATASE Up to 11 months Male 133 – 426 U/L

Female 196 – 553 U/L

11+ months – 2 years Male 133 – 287 U/L

Female 196 – 510 U/L

2+ – 8 years Male 133 – 287 U/L

Female 196 – 426 U/L

8+ – 11 years Male 133 – 340 U/L

Female 172 – 510 U/L

11+ – 15 years Male 133 – 468 U/L

Female 100 – 426 U/L

15+ – 17 years Male 60 – 340 U/L

Female 60 – 152 U/L

17+ – 18 years Male 60 – 162 U/L

Female 60 – 152 U/L

18+ – 19 years Male 60 – 162 U/L

Female 40 – 130 U/L

Adult 30 – 110 U/L

ALPHA–1 ANTITRYPSIN 0.88 – 1.74 g/L

ALT (SGPT) 4 – 43 U/L

AMYLASE 27 – 110 U/L

AMYLASE URINE Random up to 350 U/L

Per 24 hours up to 440 U/d

ANDROSTENEDIONE Male 2.1 – 10.8 nmol/L

Female 1.2 – 13.7 nmol/L

ANION GAP with K+ 10 – 20 mmol/L

no K+ 10 – 16 mmol/L

(2)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

ANTI DNA Negative < 20 IU/mL

Borderline 20 – 25 IU/mL

Positive > 25 IU/mL

AST (SGOT) 6 – 42 U/L

ASO less than 116 KU/L

BILIRUBIN TOTAL Greater than 5 days 3 – 18 mol/L

2 – 5 days 68 – 200 mol/L

Less than – 2 days 100 – 120 mol/L

BILIRUBIN DIRECT 0 – 5 mol/L

CALCIUM Greater than 18 years 2.15 – 2.60 mmol/L

11 days – 18 years 2.20 – 2.70 mmol/L

Up to 10 days 1.90 – 2.60 mmol/L

CALCIUM URINE Random 1.7 – 5.0 mmol/L

24–Hours 1.2 – 6.2 mmol/d

CARBAMAZEPINE 17 – 51 mol/L

CA125 0 - 35 U/mL

CERULOPLASMIN 200 – 640 mg/L

CHLORIDE 95 – 108 mmol/L

CHLORIDE URINE Random 15 – 250 mmol/L

24–Hour 110 – 250 mmol/d

CHOLESTEROL Less than 29 years Target less than 4.60 mmol/L Greater than 29 years Target less than 5.20 mmol/L

CHOLESTEROL/HDL RATIO If Risk Target

Low Risk less than 6.0

Moderate Risk less than 5.0

High Risk less than 4.0

CK Male less than 210 U/L

Female less than 170 U/L

CO2 21 – 31 mmol/L

COMPLEMENT C3 0.70 – 1.76 g/L

COMPLEMENT C4 0.16 – 0.45 g/L

hs CRP Low Risk less than 1.0 mg/L

Average Risk 1.0 – 3.0 mg/L

High Risk greater than 3.0 mg/L

(3)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

CORTISOL A.M. 185 – 624 nmol/L

P.M. < 280 nmol/L

Random

Cannot be determined

Free, Urine 24–Hour 138 – 524 nmol/d

Total, Urine 24–Hour 440 – 1800 nmol/d

C–PEPTIDE 298 – 2350 pmol/L

CREATININE Male (greater 10 years) 60 – 127 mol/L Female (greater 10 years) 60 – 115 mol/L

5 – 10 years 44 – 71 mol/L

Less than 5 years less than 44 mol/L

CREATININE URINE Random Male 5.0 – 13.0 mmol/L

Random Female 3.0 – 11.0 mmol/L

24–Hour Male 7.0 – 20.0 mmol/d

24–Hour Female 4.0 – 16.0 mmol/d

CREATININE CLEARANCE 1.25 – 1.92 mL/s

DHEA–S Male less than 14.1 mol/L

Female less than 11.0 mol/L

DIGOXIN 0.6 – 2.6 nmol/L

DILANTIN (PHENYTOIN) 40 – 80 mol/L

ESTRADIOL Non Pregnant Female:

Mid Follicular 99 – 448 pmol/L Mid–Cycle Peak 350 – 1590 pmol/L Mid Luteal 180 – 1068 pmol/L Post Menopausal 0 – 147 pmol/L

Male 0 – 172 pmol/L

ETHYL ALCOHOL None Detected

FERRITIN Male 25 – 200 g/L

Female 11 – 145 g/L

Newborn 5 – 100 g/L

FOLATE ERCS

(RBC FOLATE) greater than 829 nmol/L

(4)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

FSH Female:

Mid Follicular 3.9 – 8.8 IU/L Mid–Cycle Peak 4.5 – 22.5 IU/L Mid Luteal 1.8 – 5.1 IU/L Post Menopausal 16.7 – 113.6 IU/L

Male 1.3 – 19.3 IU/L

GAMMA GT (GGT) Male 5 – 50 U/L

Female 5 – 40 U/L

GASTRIN 13 – 115 ng/L

GLUCOSE FASTING New Born – 3 years 2.5 – 5.0 mmol/L Children (3 – 12 years) 2.8 – 6.1 mmol/L Adolescent (13 – 18 years) 3.3 – 6.1 mmol/L

19 years – Adult 3.3 – 6.0 mmol/L

GLUCOSE RANDOM 3.3 – 7.8 mmol/L

GLUCOSE PC 2–Hour 3.30 – 7.80 mmol/L

GLUCOSE CHALLENGE Fasting 75 g Load 3.3 – 6.0 mmol/L

2–Hour 3.3 – 7.7 mmol/L

GLUCOSE CHALLENGE 50 G LOAD (GESTATIONAL)

(GESTATIONAL SCREEN) 1–Hour 3.3 – 7.8 mmol/L

GLUCOSE TOLERANCE TEST 75 G LOAD (GESTATIONAL)

(GESTATIONAL) FBS 3.3 – 5.3 mmol/L

1–Hour 3.3 – 10.6 mmol/L

2–Hour 3.3 – 8.9 mmol/L

100 G LOAD (GESTATIONAL)

FBS (> 18 years) 3.3 – 6.1 mmol/L

FBS (up to 18 years) 2.8 – 6.1 mmol/L

1–Hour 3.3 – 10.6 mmol/L

2–Hour 3.3 – 9.2 mmol/L

3–Hour 3.3 – 8.1 mmol/L

GLYCOSYLATED

HAEMOGLOBIN (HbA1C) 0.040 – 0.060

GROWTH HORMONE Male 0 – 1.0 g/L

Female 0 – 4.0 g/L

HAPTOGLOBIN 0.40 – 1.90 g/L

(5)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

hCG Female, Non Pregnant less than 5 IU/L

Female, Pregnant:

1st week 5 – 50 IU/L

2nd week 40 – 300 IU/L

3rd week 100 – 1000 IU/L 1st trimester 10000 – 200,000 IU/L

(PEAK)

2nd trimester 3000 – 50,000 IU/L 3rd trimester 1000 – 50,000 IU/L

Male less than 2 IU/L

HDL Target greater than 1.29 mmol/L

HOMOCYSTEINE 5.0 – 15.4 mol/L

H. PYLORI Negative less than 15 U/mL

Borderline Positive 15 – 30 U/mL

Positive > 30 U/mL

HEPATITIS Negative

HIGH SENSITIVITY CRP Low Risk less than 1.0 mg/L

(hs CRP) Average Risk 1.0 – 3.0 mg/L

High Risk greater than 3.0 mg/L

IMMUNOGLOBULINS Greater than 16 Years:

IgG 5.64 – 17.65 g/L IgA 0.85 – 3.85 g/L IgM 0.45 – 2.50 g/L

IgE 0 – 432 g/L

PEDIATRIC IMMUNOGLOBULINS

Age IgG (g/L) IgA (g/L) IgM (g/L) 0 – 6 months 1.50 – 4.70 0.20 – 1.30 0.30 – 0.60 6 mos – 1 year 1.40 – 10.30 0.20 – 1.30 0.30 – 1.60 1 – 2 years 2.80 – 9.60 0.20 – 1.10 0.30 – 1.50 2 – 5 years 3.70 – 15.00 0.30 – 2.00 0.20 – 2.20 5 – 10 years 4.40 – 15.50 0.50 – 2.30 0.30 – 1.70 10 – 16 years 4.50 – 14.40 0.40 – 2.40 0.40 – 2.00

INSULIN Fasting 13 – 161 pmol/L

2-hour (post challenge)

Cannot be determined

Random

Cannot be determined

(6)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

IONIZED CALCIUM 1.15 – 1.35 mmol/L

IRON 10 – 26 mol/L

IRON SATURATION 0.25 – 0.50

LD 76 – 200 U/L

LDL If clinically determined risk is: Target for LDL-C Low reduce by 50%

Moderate or High < 2.0 or reduce by 50 %

LH Female:

Mid Follicular 2.1 – 10.9 IU/L Mid Cycle 19.2 – 103.0 IU/L Mid Luteal 1.2 – 12.9 IU/L Post Menopausal 10.9 – 58.6 IU/L

Male 1.2 – 8.6 IU/L

LITHIUM 0.6 – 1.2 mmol/L

May reflect acute toxicity ≥ 1.5 mmol/L

LEAD BLOOD Up to 16 years up to 0.48 mol/L

Male (17 yrs and above) up to 1.00 mol/L

Female (17 – 45 yrs) up to 0.48 mol/L

Female (> 45 yrs) up to 1.00 mol/L

LIPASE 13 – 80 U/L

MAGNESIUM 0.65 – 1.05 mmol/L

MICROALBUMIN Random less than 15 mg/L

24–Hour less than 21 mg/d

MICROALBUMIN/ Male less than 2.0

CREATININE RATIO Female less than 2.8

PHENOBARBITAL 65 – 172 mol/L

PHOSPHATE 0.80 – 1.52 mmol/L

PHOSPHATE URINE Random 8.7 – 28.0 mmol/L

24–Hour 13 – 42 mmol/L

POTASSIUM 3.5 – 5.2 mmol/L

POTASSIUM URINE Random 17 – 80 mmol/L

24–Hour 25 – 120 mmol/d

(7)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

PROGESTERONE Male 0.3 – 2.7 nmol/L

Female, Non Pregnant:

Mid Follicular 1.0 – 4.8 nmol/L Mid Luteal 16.4 – 59.0 nmol/L Post Menopausal < 0.3 – 2.5 nmol/L Female, Pregnant:

First Trimester 15.0 – 161.4 nmol/L Second Trimester 61.7 – 144.0 nmol/L

PROLACTIN Male 2.6 – 13.1 g/L

Female 3.3 – 26.7 g/L

PROTEIN SYNOVIAL FLUID 10 – 30 g/L

PROTEIN TOTAL 60 – 82 g/L

PROTEIN URINE RANDOM 0 – 0.15 g/L

PROTEIN URINE 24 HOUR 0 – 0.2 g/d

PSA TOTAL less than 4.00 g/L

PSA FREE less than 0.934

For Total PSA between 4 and 10 g/L, a Free/Total PSA ratio of < 0.25 is associated with an increased risk of prostate cancer.

PTH 1.3 – 8.2 pmol/L

RHEUMATOID FACTOR (RF) less than 20 IU/mL

RUBELLA Non–Immune less than 5 IU/mL

Inconclusive 5 – 10 IU/mL

Immune greater than 10 IU/mL

SODIUM 135 – 146 mmol/L

SODIUM URINE Random 20 – 230 mmol/L

24–hour 40 – 220 mmol/d

T3 FREE 2.9 – 6.0 pmol/L

T3 TOTAL 1.3 2.5 nmol/L

T4 FREE 7.2 – 21.0 pmol/L

TESTOSTERONE, TOTAL Female 0.4 – 2.6 nmol/L

(8)

BIOCHEMISTRY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS

Male 6.0 – 27.0 nmol/L

TESTOSTERONE, FREE Male 15.6 – 146 pmol/L

Female 0 – 14.2 pmol/L

THEOPHYLLINE 55 – 110 mol/L

THYROGLOBULIN < 45 pmol/L

TIBC 45 –63 mol/L

TRIGLYCERIDES Up to 18 years less than 1.20 mmol/L

Over 18 years less than 1.71 mmol/L

TSH, SENSITIVE (S–TSH) 0.3 – 5.6 mIU/L

UIBC 19 – 51 mol/L

URATE (URIC ACID) Male 180 – 450 mol/L

Female 120 – 400 mol/L

URATE (URIC ACID) URINE Random 1.0 – 3.0 mmol/L

24–hour 1.50 – 4.50 mmol/d

URATE SYNOVIAL FLUID 200 – 480 mol

UREA (BUN) 3.0 – 8.2 mmol/L

VANILMANDELIC ACID

(VMA–URINE) 10.0 – 40.0 mol/d

VALPROIC ACID 347 – 693 mol/L

VITAMIN B12 Deficient < 107 pmol/L

Indeterminate 107 – 133 pmol/L

Sufficient > 133 pmol/L

VITAMIN D (25–HYDROXY) Ideal 75 – 200 nmol/L

Toxic > 250 nmol/L

(9)

HEMATOLOGY DEPARTMENT

TEST GUIDELINES REFERENCE

RANGE UNITS BLOOD FILM (DIFFERENTIAL)

Relative Segmented Neutros 0.40 – 0.75 Frac of 1

Band Neutros 0.00 – 0.05 Frac of 1

Lymphocytes 0.20 – 0.45 Frac of 1

Monocytes 0.02 – 0.13 Frac of 1

Eosinophils 0.01 – 0.06 Frac of 1

Basophils 0.00 – 0.01 Frac of 1

Absolute Neutros 2.0 – 7.5 x109/L

Lymphocytes 1.1 – 3.3 x109/L

Monocytes 0.0 – 0.8 x109/L

Eosinophils 0.0 – 0.5 x109/L

Basophils 0.0 – 0.2 x109/L

D-DIMER < 500 µg/mL

ERCS (RBC) Male 4.5 – 6.5 x1012/L

Female 3.8 – 5.8 x1012/L

ESR. (SED. RATE) Male:

17 – 50 years 0 – 10 mm

> 50 years 0 – 14 mm

Female:

17 – 50 years 0 – 12 mm

> 50 years 0 – 20 mm

FIBRINOGEN 1.5 – 4.0 g/L

HEMATOCRIT (PCV) Male 0.37 – 0.54 Frac of 1

Female 0.37 – 0.47 Frac of 1

HEMOGLOBIN Male 135 – 180 g/L

Female 115 – 165 g/L

LKCS (WBC) 4.0 – 11.0 x109/L

MCH 27.0 – 32.0 pg

MCHC 320 – 360 g/L

MCV 80 – 97 f/L

RETICULOCYTE COUNT 25 – 85 x109/L

THROMBOCYTES (Platelets) 150 – 400 x109/L

RDW 11 – 14.5

INR 0.8 – 1.2

PTT 26 – 39 Seconds

(10)

MISCELLANEOUS

TEST GUIDELINES REFERENCE

RANGE UNITS

URINALYSIS

(Routine) Bilirubin Negative

Blood Negative

Glucose Negative

Ketones Negative

Leukocytes Esterase Negative

Nitrite Negative

pH 5 – 9

Protein Negative

Specific Gravity 1.005 – 1.030

Urobilinogen 3.2 – 16 mol/L

(Microscopic) WBC 0 – 9 p/uL

RBC 0 – 5 p/uL

Epithelials 0 – 9 p/uL

Epithelials Non-Squamous 0 – 2 p/uL

Casts (hyaline) 0 – 2 p/uL

Mucous 0 – 264 p/uL

Amorphous Phosphates 0 – 6 p/uL

Amorphous Urates 0 – 6 p/uL

Crystals

Calcium Oxalate 0 – 6 p/uL

Urate 0 – 6 p/uL

Triple Phosphate 0 -6 p/uL

Bacteria 0 - 75 p/uL

(11)

PEDIATRIC HEMATOLOGY REFERENCE RANGES

TEST BIRTH 1 WK–2 MO 3–11 MO 1–5 YR 6–10 YR 11–14 YR UNITS

TOTAL LKCS 20 – 40 5 – 21 5 – 15 5 – 12 4 – 11 4 – 11 x109/L NEUTS 6 – 26 1.5 – 10 1.5 – 8.5 1.5 – 8.5 1.5 – 8 2 – 7.5 x109/L

BANDS 0 – 0.8 0 – 0.8 0 0 0 0 x109/L

LYMPHS 2 – 11 2 – 17 4 – 10.5 2 – 8 1.5 – 7 1.1 – 3.3 x109/L MONOS 0.4 – 3.1 0.2 – 2.4 0.05 – 1.1 0 – 0.8 0 – 0.8 0 – 0.8 x109/L EOS 0.02 – 0.85 0.07 – 1 0.05 – 0.7 0.02 – 0.5 0 – 0.5 0 – 0.5 x109/L BASOS 0 – 0.2 0 – 0.2 0 – 0.2 0 – 0.2 0 – 0.2 0 – 0.2 x109/L

ERCS 3.5 – 6 3.5 – 5.5 3.5 – 5 4 – 5 4.5 – 5.5 4.5 – 5.5 x1012/L HB 150 – 250 115 – 180 100 – 140 110 – 140 120 – 160 125 – 170 g/L HCT 0.46 – 0.74 0.35 – 0.54 0.30 – 0.42 0.33 – 0.42 0.36 – 0.48 0.39 – 0.50 frac of 1

MCV 95 – 120 77 – 115 70 – 86 80 – 94 80 – 94 80 – 100 fL

MCH 33 – 39 24 – 34 24 – 31 24 – 31 24 – 31 24 – 31 pg

MCHC 320 – 360 320 – 360 320 – 360 320 – 360 320 – 360 320 – 360 g/L RETICS 200 – 300 10 – 100 10 – 100 10 – 100 10 – 100 10 – 100 x109/L PLATELETS 150 – 400 150 – 400 150 – 400 150 – 400 150 – 400 150 – 400 x109/L

References

Related documents

Students have two self-reports to use throughout the academic year; absence from course commitments including tests, quizzes, presentations, labs, and assignments that are worth

 To determine the influence of slag composition, curing duration and temperature on the resistance of slag blends to chloride ion penetration;..  To determine the

[r]

New graduate students may not select a research and thesis advisor or begin research until they have satisfactorily completed one semester of course work2. Commencement of

or Canadian institution that is accredited to offer graduate courses and degrees (credits from international institutions are transferable only after examination and approval by

In the present paper, an annotated list of the marine fishes of Galicia, including 202. 42 new records,

Using GPU data placement optimization, we examine whether ontology can indeed enable seamless linkage of various sources of knowledge (programs, domain experts, and hardware)

In this section we summarize three key results of an application of structural analysis using our estimation method based on the triangular algorithm to estimate a very large VAR